Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female

被引:22
作者
Majid, Imran [1 ]
Mearaj, Samia [1 ]
机构
[1] Cutis Inst Dermatol, Srinagar, India
关键词
adverse effects; COVID vaccine; skin; Sweet syndrome;
D O I
10.1111/dth.15146
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Vaccination for COVID19 infection is in full swing all around the world and while the vaccines are considered overall safe, many cutaneous and extracutaneous adverse effects have been reported after their use. Local injection-site reactions are the commonest adverse effect described with the use of these vaccines. We describe a case of Sweet syndrome in an elderly female after the first dose of Oxford-AstraZeneca COVID-19 vaccine (AZD1222).
引用
收藏
页数:3
相关论文
共 5 条
[1]   Cutaneous adverse effects of the available COVID-19 vaccines [J].
Bogdanov, Georgi ;
Bogdanov, Ivan ;
Kazandjieva, Jana ;
Tsankov, Nikolai .
CLINICS IN DERMATOLOGY, 2021, 39 (03) :523-531
[2]   Sweet's syndrome: A review of current treatment options [J].
Cohen P.R. ;
Kurzrock R. .
American Journal of Clinical Dermatology, 2002, 3 (2) :117-131
[3]   Sweet syndrome induced by SARS-CoV-2 Pfizer-BioNTech mRNA vaccine [J].
Darrigade, Anne-Sophie ;
Theophile, Helene ;
Sanchez-Pena, Paola ;
Milpied, Brigitte ;
Colbert, Marianne ;
Pedeboscq, Stephane ;
Pistone, Thierry ;
Jullie, Marie-Laure ;
Seneschal, Julien .
ALLERGY, 2021, 76 (10) :3194-3196
[4]   Sweet's syndrome triggered by pneumococcal vaccination [J].
Pedrosa, Ana Filipa ;
Morais, Paulo ;
Nogueira, Ana ;
Pardal, Joana ;
Azevedo, Filomena .
CUTANEOUS AND OCULAR TOXICOLOGY, 2013, 32 (03) :260-261
[5]  
RADEFF B, 1986, ACTA DERM-VENEREOL, V66, P357